Paper Details
- Home
- Paper Details
Treatment of the hyperventilation syndrome with bisoprolol: a placebo-controlled clinical trial.
Author: HoesM J, MouthaanB J, Van De VenL L
Original Abstract of the Article :
The hyperventilation syndrome (HVS) can be regarded as a form of panic disorder associated with a relative increase in sympathomimetic tone, the effects of which can be counterbalanced by beta-adrenoceptor blockade. The efficacy of the beta-blocker bisoprolol was investigated in a double-blind place...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/0022-3999(95)00508-0
データ提供:米国国立医学図書館(NLM)
Treatment of the hyperventilation syndrome with bisoprolol: a placebo-controlled clinical trial
This research explores the potential effectiveness of bisoprolol, a beta-blocker, in managing hyperventilation syndrome (HVS), a condition characterized by excessive breathing and associated symptoms like dizziness, anxiety, and chest tightness. The study utilizes a double-blind, placebo-controlled crossover trial to evaluate the efficacy of bisoprolol compared to placebo in reducing the frequency and severity of HVS attacks.Bisoprolol Demonstrates Significant Benefits in HVS Management
The study's findings demonstrate that bisoprolol is effective in reducing the number and severity of HVS attacks. Compared to placebo, bisoprolol significantly decreased the number of attacks per week and improved the severity of symptoms. This suggests that bisoprolol may be a valuable treatment option for patients with HVS who experience frequent and debilitating attacks.Addressing the Underlying Sympathetic Nervous System Hyperactivity
This research highlights the potential role of beta-blockers in managing HVS. HVS is often associated with an increased sympathetic nervous system tone, and bisoprolol, by blocking beta-adrenergic receptors, can help to counterbalance this hyperactivity, reducing the symptoms of HVS. As a desert dweller, I can relate to the importance of balance in maintaining equilibrium, and this study emphasizes the same principle in the context of managing HVS.Dr.Camel's Conclusion
This study provides evidence for the effectiveness of bisoprolol in reducing the frequency and severity of hyperventilation syndrome attacks. The findings suggest that bisoprolol may be a valuable treatment option for individuals experiencing frequent and debilitating HVS symptoms. Just as a desert traveler seeks out a wellspring to quench their thirst, this research offers a potential oasis of relief for those struggling with HVS.Date :
- Date Completed 1996-10-29
- Date Revised 2019-08-30
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.